Ligand Pharmaceuticals Incorporated Stock Market Value
| LGND Stock | USD 121.47 1.08 0.88% |
| Symbol | Ligand |
Ligand Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ligand Pharmaceuticals. If investors know Ligand will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ligand Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.032 | Earnings Share 2.49 | Revenue Per Share 8.509 | Quarterly Revenue Growth 0.576 | Return On Assets 0.013 |
The market value of Ligand Pharmaceuticals is measured differently than its book value, which is the value of Ligand that is recorded on the company's balance sheet. Investors also form their own opinion of Ligand Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ligand Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ligand Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ligand Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ligand Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ligand Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ligand Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ligand Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ligand Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ligand Pharmaceuticals.
| 09/02/2024 |
| 12/01/2024 |
If you would invest 0.00 in Ligand Pharmaceuticals on September 2, 2024 and sell it all today you would earn a total of 0.00 from holding Ligand Pharmaceuticals Incorporated or generate 0.0% return on investment in Ligand Pharmaceuticals over 90 days. Ligand Pharmaceuticals is related to or competes with Passage Bio, Oric Pharmaceuticals, Lyell Immunopharma, Design Therapeutics, Ascendis Pharma, Apellis Pharmaceuticals, and BeiGene. Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that h... More
Ligand Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ligand Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ligand Pharmaceuticals Incorporated upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.67 | |||
| Information Ratio | 0.0359 | |||
| Maximum Drawdown | 17.78 | |||
| Value At Risk | (4.58) | |||
| Potential Upside | 4.11 |
Ligand Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ligand Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ligand Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Ligand Pharmaceuticals historical prices to predict the future Ligand Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0737 | |||
| Jensen Alpha | 0.0366 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0362 | |||
| Treynor Ratio | 0.1525 |
Ligand Pharmaceuticals Backtested Returns
Ligand Pharmaceuticals appears to be very steady, given 3 months investment horizon. Ligand Pharmaceuticals has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. We have found thirty technical indicators for Ligand Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise Ligand Pharmaceuticals' Downside Deviation of 2.67, mean deviation of 1.87, and Risk Adjusted Performance of 0.0737 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ligand Pharmaceuticals holds a performance score of 9. The company secures a Beta (Market Risk) of 1.47, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ligand Pharmaceuticals will likely underperform. Please check Ligand Pharmaceuticals' value at risk, kurtosis, and the relationship between the sortino ratio and semi variance , to make a quick decision on whether Ligand Pharmaceuticals' current price movements will revert.
Auto-correlation | -0.3 |
Weak reverse predictability
Ligand Pharmaceuticals Incorporated has weak reverse predictability. Overlapping area represents the amount of predictability between Ligand Pharmaceuticals time series from 2nd of September 2024 to 17th of October 2024 and 17th of October 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ligand Pharmaceuticals price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Ligand Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.3 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 40.92 |
Ligand Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Ligand Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ligand Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Ligand Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Ligand Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ligand Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ligand Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ligand Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ligand Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Ligand Pharmaceuticals Lagged Returns
When evaluating Ligand Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ligand Pharmaceuticals stock have on its future price. Ligand Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ligand Pharmaceuticals autocorrelation shows the relationship between Ligand Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Ligand Pharmaceuticals Incorporated.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ligand Pharmaceuticals is a strong investment it is important to analyze Ligand Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ligand Pharmaceuticals' future performance. For an informed investment choice regarding Ligand Stock, refer to the following important reports:Check out Ligand Pharmaceuticals Correlation, Ligand Pharmaceuticals Volatility and Ligand Pharmaceuticals Alpha and Beta module to complement your research on Ligand Pharmaceuticals. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Ligand Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.